THE USE OF STATINS AND DRUGS THAT INHIBIT THE ABSORPTION OF CHOLESTEROL IN PATIENTS WITH CORONARY HEART DISEASE
Main Article Content
Abstract
Dyslipidemia is one of the main risk factors for the development of coronary artery disease. Epidemiological studies in recent years have shown a direct correlation between lipid metabolism disorders and the risk of developing cardiovascular complications. In this regard, it has been proven that the appointment of lipid-lowering therapy not only removes the level of cholesterol, but also prevents the development of both primary and repeated heart attacks and strokes, etc. Improves the quality and prognosis of patients' life.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
TheLIPIDstudygroup.//AmJCardiol 1995; 76: 474-9.
TheWOSCOPSgroup. WestofScotlandCoronarypreventionstudy: implications for clinical practice.//Eur Heart J 1996; 17: 163-4
Stenestrand U, et al. Early statin treatment following acute myocardial infarction and 1 - year survival. // JAMA 2001; 285: 430-436
Yarmukhamedova S. Kh., Bekmuradova M. S. Development of heart failure in patients with essential hypertension in terms of natriuretic peptide // Eurasian cardiological journal. - 2019. - No. S2. - S. 283-284.
Shwartz GG, et al. Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACLE) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardia infarction.//Am J Cardiol 1998; 81578-81
Samiev U.B. et al. Myocardial infarction in elderly and senile age. Features of the clinical course and diagnosis // Advances in science and education. - 2019. - No. 12 (53).
Samiev U.B., Khaidarova D.S. Clinical and physiological features of painless myocardial ischemia in elderly and senile age. IP Pavlova with international participation. - 2017 .-- S. 164-165.
IMS Health, National Prescription Audit; 200.
Yarmukhamedova S. Kh., Nazarov F. Yu. Assessment of structural and functional disorders of the heart in patients with arterial hypertension according to Doppler echocardiography // National Association of Scientists. - 2016. - No. 1. - p. 16-17.
Libov A.I., Roitman A.P. and other Indicators of lipid metabolism in the acute period of myocardial infarction. Proceedings of the scientific and practical conference. Topical issues of clinical medicine. Moscow 2000.
Samiev U.B., Gafforov Kh. Kh., Makhmudova Kh.D. Spirographic efficacy of intravenous administration of isosorbitadinitrate (isoket) in patients with chronic heart failure // Achievements of Science and Education. - 2019. - No. 12 (53).
Bekmuradova, Makhsuda Salhiddinovna, Khudoyor Khudoyberdievich Gafforov, and Suvon Totliboevich Yarmatov. "The value of brain natriuretic peptide determination in the diagnosis of chronic heart failure." Achievements in science and education 4 (58) (2020).
Bekmuradova, M. S., Kh.D. Makhmudova, and F. Yu. Nazarov. "DIAGNOSTIC SIGNIFICANCE OF BRAIN SODIUM-URETIC PEPTIDE IN DETECTING CHRONIC HEART FAILURE." Scientific progress 2.1 (2021): 810-814.